Hunter Robyn 4
4 · TENAX THERAPEUTICS, INC. · Filed Jan 13, 2026
Insider Transaction Report
Form 4
Hunter Robyn
Director
Transactions
- Award
Stock Option (right to buy)
2026-01-09+30,000→ 30,000 totalExercise: $13.30From: 2027-01-09Exp: 2036-01-09→ Common Stock (30,000 underlying)
Holdings
- 4
Stock Option (right to buy)
Exercise: $992.00From: 2023-06-09Exp: 2032-06-09→ Common Stock (4 underlying) - 100,000
Stock Option (right to buy)
Exercise: $5.94From: 2025-12-10Exp: 2034-12-10→ Common Stock (100,000 underlying) - 80,000
Stock Option (right to buy)
Exercise: $5.75From: 2026-07-01Exp: 2035-07-01→ Common Stock (80,000 underlying)
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact|2026-01-13